Jiangsu Nanfang Medical - Asset Resilience Ratio

Latest as of June 2026: 2.57%

Jiangsu Nanfang Medical (603880) has an Asset Resilience Ratio of 2.57% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jiangsu Nanfang Medical current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥22.50 Million

≈ $3.29 Million USD Cash + Short-term Investments

Total Assets

CN¥874.85 Million

≈ $128.02 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Jiangsu Nanfang Medical's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Jiangsu Nanfang Medical.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Nanfang Medical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 603880 liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥22.50 Million	2.57%
Total Liquid Assets	CN¥22.50 Million	2.57%

Asset Resilience Insights

Limited Liquidity: Jiangsu Nanfang Medical maintains only 2.57% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jiangsu Nanfang Medical Industry Peers by Asset Resilience Ratio

Compare Jiangsu Nanfang Medical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SDI Ltd AU:SDI	Medical Instruments & Supplies	3.36%
Austco Healthcare Ltd AU:AHC	Medical Instruments & Supplies	15.90%
Trajan Group Holdings Ltd AU:TRJ	Medical Instruments & Supplies	0.29%
Osteopore Ltd AU:OSX	Medical Instruments & Supplies	22.60%
Nyxoah BR:NYXH	Medical Instruments & Supplies	12.40%
ZEN Graphene Solutions Ltd V:ZEN	Medical Instruments & Supplies	4.79%

Annual Asset Resilience Ratio for Jiangsu Nanfang Medical (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Jiangsu Nanfang Medical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.42%	CN¥22.50 Million ≈ $3.29 Million	CN¥927.94 Million ≈ $135.79 Million	+0.29pp
2024-12-31	2.13%	CN¥22.52 Million ≈ $3.30 Million	CN¥1.06 Billion ≈ $154.61 Million	+0.37pp
2023-12-31	1.76%	CN¥22.52 Million ≈ $3.30 Million	CN¥1.28 Billion ≈ $186.91 Million	+0.31pp
2022-12-31	1.46%	CN¥21.23 Million ≈ $3.11 Million	CN¥1.46 Billion ≈ $213.24 Million	-0.16pp
2021-12-31	1.62%	CN¥20.00 Million ≈ $2.93 Million	CN¥1.24 Billion ≈ $180.75 Million	-2.98pp
2019-12-31	4.60%	CN¥40.00 Million ≈ $5.85 Million	CN¥869.60 Million ≈ $127.25 Million	-2.69pp
2017-12-31	7.29%	CN¥60.00 Million ≈ $8.78 Million	CN¥822.96 Million ≈ $120.43 Million	--

pp = percentage points

About Jiangsu Nanfang Medical

SHG:603880 China Medical Instruments & Supplies

Market Cap

$375.59 Million

CN¥2.57 Billion CNY

Market Cap Rank

#13838 Global

#4151 in China

Share Price

CN¥8.88

Change (1 day)

-8.55%

52-Week Range

CN¥5.74 - CN¥10.23

All Time High

CN¥16.80